FI20050640A0 - Föreningar för behandling eller förhindrande av sjukdomar eller störningar releterade till amin-oxidaser - Google Patents

Föreningar för behandling eller förhindrande av sjukdomar eller störningar releterade till amin-oxidaser

Info

Publication number
FI20050640A0
FI20050640A0 FI20050640A FI20050640A FI20050640A0 FI 20050640 A0 FI20050640 A0 FI 20050640A0 FI 20050640 A FI20050640 A FI 20050640A FI 20050640 A FI20050640 A FI 20050640A FI 20050640 A0 FI20050640 A0 FI 20050640A0
Authority
FI
Finland
Prior art keywords
treating
compounds
disorders related
preventing diseases
amine oxidases
Prior art date
Application number
FI20050640A
Other languages
English (en)
Finnish (fi)
Inventor
Sirpa Jalkanen
Markku Jalkanen
Marko Salmi
Original Assignee
Faron Pharmaceuticals Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faron Pharmaceuticals Oy filed Critical Faron Pharmaceuticals Oy
Priority to FI20050640A priority Critical patent/FI20050640A0/sv
Publication of FI20050640A0 publication Critical patent/FI20050640A0/sv
Priority to PCT/FI2006/000188 priority patent/WO2006134203A1/en
Priority to US11/917,638 priority patent/US20110038922A1/en
Priority to EP06764414A priority patent/EP1890711A4/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y104/00—Oxidoreductases acting on the CH-NH2 group of donors (1.4)
    • C12Y104/03—Oxidoreductases acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3)
    • C12Y104/03021—Primary-amine oxidase (1.4.3.21), i.e. VAP-1
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.

Landscapes

  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI20050640A 2005-06-16 2005-06-16 Föreningar för behandling eller förhindrande av sjukdomar eller störningar releterade till amin-oxidaser FI20050640A0 (sv)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FI20050640A FI20050640A0 (sv) 2005-06-16 2005-06-16 Föreningar för behandling eller förhindrande av sjukdomar eller störningar releterade till amin-oxidaser
PCT/FI2006/000188 WO2006134203A1 (en) 2005-06-16 2006-06-12 Compounds for treating or preventing amine oxidase related diseases or disorders
US11/917,638 US20110038922A1 (en) 2005-06-16 2006-06-12 Compounds for treating or preventing amine oxidase related diseases or disorders
EP06764414A EP1890711A4 (en) 2005-06-16 2006-06-12 COMPOUNDS FOR THE TREATMENT OR PREVENTION OF AMINOXIDASE-RELATED DISEASES OR DISEASES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20050640A FI20050640A0 (sv) 2005-06-16 2005-06-16 Föreningar för behandling eller förhindrande av sjukdomar eller störningar releterade till amin-oxidaser

Publications (1)

Publication Number Publication Date
FI20050640A0 true FI20050640A0 (sv) 2005-06-16

Family

ID=34778360

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20050640A FI20050640A0 (sv) 2005-06-16 2005-06-16 Föreningar för behandling eller förhindrande av sjukdomar eller störningar releterade till amin-oxidaser

Country Status (4)

Country Link
US (1) US20110038922A1 (sv)
EP (1) EP1890711A4 (sv)
FI (1) FI20050640A0 (sv)
WO (1) WO2006134203A1 (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090170770A1 (en) * 2007-11-06 2009-07-02 Ali Hafezi-Moghadam Methods and compositions for treating conditions associated with angiogenesis using a vascular adhesion protein-1 (vap 1) inhibitor
ES2338400B1 (es) * 2008-05-06 2011-09-14 David Benet Ferrus Conjunto de moleculas antiangiogenicas y su uso.
FI20090161A0 (sv) 2009-04-22 2009-04-22 Faron Pharmaceuticals Oy Ny cell och terapeutiska och diagnostiska metoder baserade därpå
AU2014279863A1 (en) 2013-06-12 2016-01-28 Proximagen Limited New therapeutic uses of enzyme inhibitors
WO2015189534A1 (en) 2014-06-12 2015-12-17 Proximagen Limited Vap-1 inhibitors for treating muscular dystrophy
EP3777846A1 (en) 2015-12-07 2021-02-17 BenevolentAI Cambridge Limited Vap-1 inhibitors for treating pain

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580780A (en) * 1992-06-09 1996-12-03 Jalkanen; Sirpa Vascular adhesion protein-(VAP-1) and VAP-1-specific antibodies
NZ501118A (en) * 1997-05-23 2002-08-28 Biotie Therapies Corp Vascular adhesion protein-1 having amine oxidase activity
AU2001245489A1 (en) * 2000-03-07 2001-09-17 Whitehead Institute For Biomedical Research Human single nucleotide polymorphisms
MXPA03004836A (es) * 2000-12-01 2005-09-08 Max Planck Gesellschaft Moleculas pequenas de arn que median la interferencia de arn.
EP1386004A4 (en) * 2001-04-05 2005-02-16 Ribozyme Pharm Inc MODULATION OF GENE EXPRESSION ASSOCIATED WITH INFLAMMATORY PROLIFERATION AND GROWTH OF NEURITIES BY METHODS INVOLVING NUCLEIC ACID
AU2003287228A1 (en) * 2002-10-25 2004-07-14 Curagen Corporation Methods of identifying compounds that modulate protein activity
EP2305813A3 (en) * 2002-11-14 2012-03-28 Dharmacon, Inc. Fuctional and hyperfunctional sirna
CA2520957C (en) * 2003-03-31 2013-08-06 Sucampo Ag Method for treating vascular hyperpermeable disease

Also Published As

Publication number Publication date
WO2006134203A1 (en) 2006-12-21
EP1890711A4 (en) 2010-08-18
EP1890711A1 (en) 2008-02-27
US20110038922A1 (en) 2011-02-17

Similar Documents

Publication Publication Date Title
LTPA2018509I1 (lt) Piperazinu pakeisti benzotiofenai, skirti psichikos sutrikimų gydymui
DK1937633T3 (da) Biphenyloxyeddikesyrederivater til behandling af respiratoriske sygdomme
WO2006113919A3 (en) Aryl alkyl acid derivatives for and use thereof
CY2016017I1 (el) Συνθεση για θεραπεια πνευμονικης υπερτασης
DK3456707T3 (da) 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme
ATE527241T1 (de) Pyridiazinonderivate zur behandlung von tumoren
SMP200900085B (it) 3-imidazolil-indoli per il trattamento di malattieproliferative.
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
ATE429218T1 (de) Pinolensäure zur behandlung von übergewicht
ATE542823T1 (de) 4,5-dihydro-ä1,2,4ütriazoloä4,3-füpteridine als plk1-proteinkinasehemmer zur behandlung proliferativer erkrankungen
ATE493986T1 (de) Diarylharnstoffe zur behandlung von pulmonaler hypertonie
BRPI0816784A2 (pt) Fatores neuro-endócrinos para o tratamento de doenças degenerativas
DE602005023172D1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
DK2056842T3 (da) Modificeret galactosylceramid til behandling af cancerøse sygdomme
BRPI0911577A2 (pt) derivados espiro-indol para o tratamento de doenças parasíticas.
DE602006010449D1 (de) Behandlung von geflügel zwecks reduzierung der futon ascites
BRPI0812755A2 (pt) Compostos de derivados de fenil alquinila para tratar doenças, e desordens oftálmicas
DK1993589T3 (da) Behandlinger for neurologiske sygdomme
WO2010030891A3 (en) Aryl guanidine f1f0-atpase inhibitors and related methods
ATE502944T1 (de) 2-amino-5,7-dihydro-6h-pyrroloä3,4- düpyrimidinderivate als hsp-90-inhibitoren zur behandlung von krebs
DK1817282T3 (da) Til behandling af respiratoriske sygdomme egnede phenoxy derivater
DK1907374T3 (da) Til behandling af gastrointestinale sygdomme anvendelige benzylpiperazin-derivater
FI20095600A (sv) Komposition för behandling av hudsjukdomar
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
EP1890711A4 (en) COMPOUNDS FOR THE TREATMENT OR PREVENTION OF AMINOXIDASE-RELATED DISEASES OR DISEASES

Legal Events

Date Code Title Description
FD Application lapsed